Rediff.com« Back to articlePrint this article

Unilever to raise stake in HUL in $5.4 billion offer

April 30, 2013 11:23 IST

Anglo-Dutch consumer goods giant Unilever Plc will pay as much as $5.4 billion to raise its stake in its Indian unit, Hindustan Unilever, to up to 75 per cent in a bet on fast-growing spending power in Asia's third-largest economy.

Unilever said it would acquire up to 487 million shares, or 22.52 per cent of the equity, of Hindustan Unilever in an open offer for Rs 600 a share, 20.6 per cent premium to Monday's closing price.

The bid sent shares in Hindustan Unilever, India's largest consumer goods maker, surging 20 per cent to an all-time high on Tuesday morning.

"This represents a further step in Unilever's strategy to invest in emerging markets and offers a liquidity opportunity at what we believe to be an attractive premium for existing shareholders," Unilever's chief executive, Paul Polman, said in a statement.

Indian law requires a minimum public shareholding of 25

per cent for a publicly listed company.

The offer, payable in cash, is expected to begin in June 2013 and at $5.4 billion would be the largest equity offer ever in India.

HSBC is the manager to the offer.

"It makes a lot of sense to increase stake if the company is serious about staying here for long term," said G. Chokkalingam, chief investment officer of Centrum Wealth Managers, which bought a small stake in Hindustan Unilever after the company reported results on Monday.

"In the long term, we expect there will be more incentive for the parent company to share technology to the Indian unit, introduce more brands here, and raise market share," he said.

Last November, GlaxoSmithKline Plc (GSK.L) offered to buy an additional 31.8 per cent stake in its India consumer products business for about $940 million.

(Additional reporting by Kaustubh Kulkarni and Sumeet Chatterjee)

Swati Pandey in Mumbai
Source: REUTERS
© Copyright 2024 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.